Mettler-Toledo International, Inc. $MTD Shares Purchased by Voleon Capital Management LP

Key Points

• Voleon Capital Management LP significantly increased its stake in Mettler-Toledo International by 171.0% during the 1st quarter, holding shares worth $1,808,000 after acquiring an additional 966 shares.
• Mettler-Toledo reported earnings of $10.09 per share for the last quarter, exceeding analysts' expectations of $9.58, with a revenue of $983.22 million compared to an estimate of $957.41 million.
• Institutional investors hold 95.07% of Mettler-Toledo's stock, and in recent analyst ratings, the stock has a consensus rating of "Moderate Buy" with an average target price of $1,311.11.

Voleon Capital Management LP lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 171.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,531 shares of the medical instruments supplier's stock after buying an additional 966 shares during the quarter. Voleon Capital Management LP's holdings in Mettler-Toledo International were worth $1,808,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of MTD. GAMMA Investing LLC grew its holdings in shares of Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after buying an additional 385,864 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Mettler-Toledo International during the first quarter worth about $71,897,000. Jones Financial Companies Lllp grew its holdings in shares of Mettler-Toledo International by 27,938.9% during the first quarter. Jones Financial Companies Lllp now owns 49,068 shares of the medical instruments supplier's stock worth $57,945,000 after buying an additional 48,893 shares in the last quarter. Finally, AustralianSuper Pty Ltd grew its holdings in shares of Mettler-Toledo International by 60.4% during the first quarter. AustralianSuper Pty Ltd now owns 114,986 shares of the medical instruments supplier's stock worth $135,788,000 after buying an additional 43,313 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 over the last ninety days. Corporate insiders own 0.77% of the company's stock.

Mettler-Toledo International Price Performance

MTD stock traded down $24.66 during midday trading on Friday, reaching $1,258.06. 109,047 shares of the company's stock traded hands, compared to its average volume of 118,112. The company has a market capitalization of $25.92 billion, a P/E ratio of 31.86, a PEG ratio of 3.78 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The business has a 50-day moving average price of $1,258.94 and a two-hundred day moving average price of $1,184.82.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International's revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the company posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on MTD shares. Evercore ISI lowered their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Citigroup boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Barclays started coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Finally, Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.